Skip to main content

Novel Rx

    Rheumatology Roundup
    Drs. Jack Cush and Arthur Kavanaugh discuss highlights and key takeaways from ACR 23. This included the following abstracts: 0025 Cannibinoids & pain 1584 TMP/SMX in GPA 0607 CAR-T cells in…
    Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA

    Dr. Robert Chao (Tysons, VA) discusses Abst
    6 months 1 week ago
    Secukinumab vs. Adalimumab Biosimilar on Radiographic Progression in AxSpA Dr. Robert Chao (Tysons, VA) discusses Abstract 0522 presented at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/UmcbplfGhB https://t.co/R5Lr6Q0qHI
    Daily Recap - WEDNESDAY
    Reminder of data for dose reduction #bDMARD by Prof Emery #ACR23

    Feasible after early remission induction https://t.co/
    6 months 1 week ago
    Reminder of data for dose reduction #bDMARD by Prof Emery #ACR23 Feasible after early remission induction https://t.co/WwiNp8WKDC
    Thanks #ACR23 for a wonderful meeting ! Presented a really positive phase 2 clinical trial results of Dazukibart, an IFN
    6 months 1 week ago
    Thanks #ACR23 for a wonderful meeting ! Presented a really positive phase 2 clinical trial results of Dazukibart, an IFN beta monoclonal antibody in #Myositis (DM) #pfizer .Strong efficacy with rapid onset. Safe & tolerable monthly IV injection. Looking forward to start Phase 3. https://t.co/580ICHM8Hs
    Large French study on infection risk of PsA biologics
    12k pts over 6 years
    When compared to Humira, only Enbrel and Ste
    6 months 1 week ago
    Large French study on infection risk of PsA biologics 12k pts over 6 years When compared to Humira, only Enbrel and Stelara had lower infection risk Concurrent steroid use associated with increased infection 1.85HR @RheumNow #ACR23 Abs#2566 https://t.co/Os1esuodfl